Reviewing a Research Study in the Biomedical Domain Series – Special Considerations (Part 4 of 4) Institution License


Webinar Objectives:

  • To highlight special considerations in the review of a bio-medical study including: considerations for studies involving new unregulated investigational interventions, studies involving investigational agents accessed through Health Canada’s Special Access Program as compared to the standard investigational testing regulatory authorization route, and therapeutic misconception from various stakeholder perspectives. These criteria will be covered with the intent of addressing the application of appropriate ethical principles for the review and approval of biomedical research studies impacted by these considerations.

Duration:  1 hour.
Date:  February 18, 2022
Time:  12:00 – 1:00 pm EST